EU5 Gaucher's Disease Report 2017 - Market Insights, Epidemiology and Market Forecast 2010-2023 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Gaucher's disease - Market Insights, Epidemiology and Market Forecast - 2023 - EU5" drug pipelines to their offering.

Gaucher's disease - Market Insights, Epidemiology and Market Forecast - 2023 - EU5 Reports provides an overview of the disease and global market size of the Gaucher disease for the EU5. It also includes global historical and forecasted epidemiological data for the diagnosed prevalent cases of Gaucher disease from 2010-2023.

Gaucher disease is an inherited genetic disease that causes fatty lipid deposits to build up in certain organs and bones. It is an autosomal recessive disorder. Gaucher Disease is the second most common lysosomal storage disorder. These fatty deposits are of an enzyme glucocerebrosidase in the lymphocyte which leads to bloating of cells.

Scope:

  • Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
  • Marketed information including available prescription drugs, its patent and exclusivity details.
  • The report also covers the detailed global historical and forecasted epidemiological data covering EU5 from 2010-2023.
  • It also provides Market size of Gaucher's disease for EU5 from 2010 and forecasted Market size to 2023.

Key Topics Covered:

  1. Introduction
  2. Gaucher's Disease Market Overview at a Glance
  3. Total Market Size of Gaucher's Disease in 2015
  4. Total Market Size of Gaucher's Disease in 2023
  5. Gaucher Disease
  6. Overview
  7. Symptoms
  8. Types of Gaucher Disease
  9. Pathophysiology
  10. Inheritance and Genetics related to Gaucher's Disease
  11. Mutations
  12. Diagnosis
  13. Treatment
  14. Epidemiology and Patient Population
  15. Marketed Drugs
  • Cerdelga
  • Zavesca
  • Cerezyme
  • Vpriv
  • Elelyso
  • Abcertin

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/44vmfx/gauchers_disease

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Endocrine and Metabolic Disorders Drugs, Endocrine and Metabolic Disorders Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Endocrine and Metabolic Disorders Drugs, Endocrine and Metabolic Disorders Drugs